Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis

Arthritis Rheum. 2005 Oct 15;53(5):788-91. doi: 10.1002/art.21468.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / therapeutic use*
  • Dermatologic Agents / therapeutic use*
  • Female
  • Humans
  • Infliximab
  • Male
  • Middle Aged
  • Retrospective Studies
  • Sarcoidosis / complications
  • Sarcoidosis / drug therapy*
  • Sarcoidosis / pathology
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab